ADORE -- Attention-Deficit Hyperactivity Disorder Observational Research in Europe
- PMID: 15322955
- DOI: 10.1007/s00787-004-1004-8
ADORE -- Attention-Deficit Hyperactivity Disorder Observational Research in Europe
Abstract
Background: Since there is little information about the naturalistic way of treatment in daily European practice, the Attention-Deficit Hyperactivity Disorder Observational Research in Europe (ADORE) project was designed as a prospective, non-interventional study of approximately 1,500 patients observed by approximately 300 investigators in various European regions.
Objective: The primary objective is the description of the relationship between treatment regimen prescribed and quality of life in ADHD patients over a two-year period.
Method: The naturalistic care provided and the outcomes (psychopathology, quality of life) are recorded at 7 data collection points.
Results: The present preliminary report provides data on the first 315 patients who were included in the study by the beginning of January 2004. The data provide an impression of the sample characteristics, the clinical diversity, and the effects of ADHD on school careers and social activities. Furthermore, treatment information dealing with the time both before and at baseline is given.
Conclusion: Even with this limited sample the negative effects on psychosocial development and quality of life in ADHD children are apparent.
Similar articles
-
Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study.Eur Child Adolesc Psychiatry. 2006 Dec;15 Suppl 1:I4-14. doi: 10.1007/s00787-006-1002-0. Eur Child Adolesc Psychiatry. 2006. PMID: 17177015
-
The provision and nature of ADHD services for children/adolescents in the UK: results from a nationwide survey.Clin Child Psychol Psychiatry. 2008 Apr;13(2):287-304. doi: 10.1177/1359104507086347. Clin Child Psychol Psychiatry. 2008. PMID: 18540230
-
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844. Pediatrics. 2004. PMID: 15520087
-
Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. NIH Consens Statement. 1998. PMID: 10868163 Review.
-
Transition in ADHD: attention to the lifespan.Australas Psychiatry. 2017 Apr;25(2):126-129. doi: 10.1177/1039856216671665. Epub 2016 Sep 30. Australas Psychiatry. 2017. PMID: 27694644 Review.
Cited by
-
Which factors impact on clinician-rated impairment in children with ADHD?Eur Child Adolesc Psychiatry. 2006 Dec;15 Suppl 1:I30-7. doi: 10.1007/s00787-006-1005-x. Eur Child Adolesc Psychiatry. 2006. PMID: 17177013
-
Predictors of diagnostic delay in a clinical sample of French children with attention-deficit/hyperactivity disorder.Eur Child Adolesc Psychiatry. 2007 Dec;16(8):505-9. doi: 10.1007/s00787-007-0627-y. Epub 2007 Sep 14. Eur Child Adolesc Psychiatry. 2007. PMID: 17876509
-
The Family Strain Index (FSI). Reliability, validity, and factor structure of a brief questionnaire for families of children with ADHD.Eur Child Adolesc Psychiatry. 2006 Dec;15 Suppl 1:I72-8. doi: 10.1007/s00787-006-1010-0. Eur Child Adolesc Psychiatry. 2006. PMID: 17177019
-
Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries.Drugs Context. 2013 Sep 13;2013:212260. doi: 10.7573/dic.212260. eCollection 2013 Sep 13. Drugs Context. 2013. PMID: 24432046 Free PMC article.
-
Comorbidities in ADHD children treated with methylphenidate: a database study.BMC Psychiatry. 2013 Jan 7;13:11. doi: 10.1186/1471-244X-13-11. BMC Psychiatry. 2013. PMID: 23294623 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical